Literature DB >> 10987093

From the outside in: extracellular activities of HIV Tat.

D Noonan1, A Albini.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10987093     DOI： 10.1016/s1054-3589(00)48008-7

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  26 in total

1.  Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors.

Authors:  Kylene Kehn-Hall; Irene Guendel; Lawrence Carpio; Leandros Skaltsounis; Laurent Meijer; Lena Al-Harthi; Joseph P Steiner; Avindra Nath; Olaf Kutsch; Fatah Kashanchi
Journal:  Virology       Date:  2011-04-22       Impact factor: 3.616

2.  HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses.

Authors:  Agnès Vendeville; Fabienne Rayne; Anne Bonhoure; Nadir Bettache; Philippe Montcourrier; Bruno Beaumelle
Journal:  Mol Biol Cell       Date:  2004-03-12       Impact factor: 4.138

3.  Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine.

Authors:  Udaykumar Ranga; Raj Shankarappa; Nagadenahalli B Siddappa; Lakshmi Ramakrishna; Ramalingam Nagendran; Marthandan Mahalingam; Anita Mahadevan; Narayana Jayasuryan; Parthasarathy Satishchandra; Susarla K Shankar; Vinayaka R Prasad
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 4.  Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications.

Authors:  Allison H Bartlett; Pyong Woo Park
Journal:  Expert Rev Mol Med       Date:  2010-02-01       Impact factor: 5.600

5.  Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.

Authors:  Irene Guendel; Sergey Iordanskiy; Rachel Van Duyne; Kylene Kehn-Hall; Mohammed Saifuddin; Ravi Das; Elizabeth Jaworski; Gavin C Sampey; Svetlana Senina; Leonard Shultz; Aarthi Narayanan; Hao Chen; Benjamin Lepene; Chen Zeng; Fatah Kashanchi
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

6.  HIV-1 Tat Protein Activates both the MyD88 and TRIF Pathways To Induce Tumor Necrosis Factor Alpha and Interleukin-10 in Human Monocytes.

Authors:  Rémi Planès; Nawal Ben Haij; Kaoutar Leghmari; Manutea Serrero; Lbachir BenMohamed; Elmostafa Bahraoui
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

7.  Molecular basis of the internalization of bovine immunodeficiency virus Tat protein.

Authors:  Gang Deng; Yang Su; Junjie Mu; Rina Sha; Yunqi Geng; Wentao Qiao; Qimin Chen
Journal:  Virus Genes       Date:  2007-10-19       Impact factor: 2.332

Review 8.  Macrophage signaling in HIV-1 infection.

Authors:  Georges Herbein; Gabriel Gras; Kashif Aziz Khan; Wasim Abbas
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

Review 9.  Human Immunodeficiency Virus Infection and Host Defense in the Lungs.

Authors:  Tysheena P Charles; Judd E Shellito
Journal:  Semin Respir Crit Care Med       Date:  2016-03-14       Impact factor: 3.119

10.  Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.

Authors:  Antonella Bugatti; Chiara Urbinati; Cosetta Ravelli; Erik De Clercq; Sandra Liekens; Marco Rusnati
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.